The present invention claims priority to U.S. application Ser. No. 13/362,467 entitled “Electrospinning Process for Manufacture of Multi-Layered Structures,” filed Jan. 31, 2012.
The present invention generally relates to fiber structures and methods of forming fiber structures using wedge-shaped vessels.
Macro-scale structures formed from concentrically-layered nanoscale or microscale fibers (“core-sheath fibers”) are useful in a wide range of applications including drug delivery, tissue engineering, nanoscale sensors, self-healing coatings, and filters. On a commercial scale, the most commonly used techniques for manufacturing core-sheath fibers are extrusion, fiber spinning, melt blowing, and thermal drawing. None of these methods, however, are ideally suited to producing drug-loaded core-sheath fibers, as they all utilize high temperatures which may be incompatible with thermally labile materials such as drugs or polypeptides. Additionally, fiber spinning, extrusion and melt-blowing are most useful in the production of fibers with diameters greater than ten microns.
Core-sheath fibers can be produced by electrospinning, in which an electrostatic force is applied to a polymer solution to form very fine fibers. Conventional electrospinning methods utilize a charged needle to supply a polymer solution, which is then ejected in a continuous stream toward a grounded collector. After removal of solvents by evaporation, a single long polymer fiber is produced. Core-sheath fibers have been produced using emulsion-based electrospinning methods, which exploit surface energy to produce core-sheath fibers, but which are limited by the relatively small number of polymer mixtures that will emulsify, stratify, and electrospin. Core-sheath fibers have also been produced using coaxial electrospinning, in which concentric needles are used to eject different polymer solutions: the innermost needle ejects a solution of the core polymer, while the outer needle ejects a solution of the sheath polymer. This method is particularly useful for fabrication of core-sheath fibers for drug delivery in which the drug-containing layer is confined to the center of the fiber and is surrounded by a drug-free layer. However, both emulsion and coaxial electrospinning methods can have relatively low throughput, and are not ideally suited to large-scale production of core-sheath fibers. To increase throughput, coaxial nozzle arrays have been utilized, but such arrays pose their own challenges, as separate nozzles may require separate pumps, the multiple nozzles may clog, and interactions between nozzles may lead to heterogeneity among the fibers collected. Another means of increasing throughput, which utilizes a spinning drum immersed in a bath of polymer solution, has been developed by the University of Liberec and commercialized by Elmarco, S.R.O. under the mark Nanospider®. The Nanospider® improves throughput relative to other electrospinning methods, but it is not currently possible to manufacture core-sheath fibers using the Nanospider®. There is, accordingly, a need for a mechanically simple, high-throughput means of manufacturing core-sheath fibers.
The present invention addresses the need described above by providing systems and methods for high-throughput production of core-sheath fibers.
In one aspect the present invention relates to an apparatus used for the electrospinning of core-sheath structures such as fibers. The apparatus comprises first and second wedge-shaped vessels, each having a slit at an apex. The first vessel is disposed inside of the second vessel such that each of the slits of the vessels is aligned. The apparatus includes means for applying a voltage source to one or more materials contained within fluid reservoirs that are in fluid communication with the wedge-shaped vessels. The apparatus also includes means for pumping fluid from one or both of the reservoirs to the wedge-shaped vessels.
Another aspect the present invention relates to a method of forming a structure comprising a core including a first material and a sheath including a second material around said core. The method comprises the steps of providing an apparatus comprising first and second wedge-shaped vessels, each having a slit at an apex thereof where the first vessel is disposed inside of the second vessel such that the first and second slits are aligned. The method further comprises the step of introducing first and second materials, at least one of which is electrically conductive, into the first and second wedge-shaped vessels. The method further comprises the step of applying a voltage of between 1 and 100 kV to at least one of the first and second materials, and pumping the first and second fluids from the fluid reservoirs to the wedge-shaped vessels.
In the drawings, like reference characters generally refer to the same parts throughout the different views. Drawings are not necessarily to scale, as emphasis is placed on illustration of the principles of the invention.
The present invention relates to electrospun fibers, including drug-containing electrospun fibers, that are produced in a high yield manner. The fibers are formed into a core-sheath configuration, such that in cross section, the fiber includes a central core as an inner radial portion surrounded by a sheath having an outer radial portion, as is known in the art. Fibers of the present invention preferably have a total diameter of no more than about 20 microns.
Examples of biodegradable polymers that can be used with the present invention to form the core and/or sheath portions of a fiber include: polyesters, such as poly(ε-caprolactone), polyglycolic acid, poly(L-lactic acid), poly(DL-lactic acid); copolymers thereof such as poly(lactide-co-ε-caprolactone), poly(glycolide-co-ε-caprolactone), poly(lactide-co-glycolide), copolymers with polyethylene glycol (PEG); branched polyesters, such as poly(glycerol sebacate); polypropylene fumarate); poly(ether esters) such as polydioxanone; poly(ortho esters); polyanhydrides such as poly(sebacic anhydride); polycarbonates such as poly(trimethylcarbonate) and related copolymers; polyhydroxyalkanoates such as 3-hydroxybutyrate, 3-hydroxyvalerate and related copolymers that may or may not be biologically derived; polyphosphazenes; poly(amino acids) such as poly (L-lysine), poly (glutamic acid) and related copolymers. Examples of other dissolvable or resorbable polymers include polyethylene glycol and poly(ethylene glycol-propylene glycol) copolymers that are known as pluronics and reverse pluronics.
Examples of biologically derived restorable polymers that can be used with the present invention include: polypeptides such as collagen, elastin, albumin and gelatin; glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparan sulfate and heparin; chitosan and chitin; agarose; wheat gluten; polysaccharides such as starch, cellulose, pectin, dextran and dextran sulfate; and modified polysaccharides such as carboxymethylcellulose and cellulose acetate.
Examples of non-biodegradable polymers that can be used with the present invention include: nylon 4, 6; nylon 6; nylon 6,6; nylon 12; polyacrylic acid; polyacrylonitrile; poly(benzimidazole) (PBI); poly(etherimide) (PEI); poly(ethylenimine); poly(ethylene terephthalate); polystyrene; poly(styrene-block-isobutylene-block-styrene); polysulfone; polyurethane; polyurethane urea; polyvinyl alcohol; poly(N-vinylcarbazole); polyvinyl chloride; poly (vinyl pyrrolidone); poly(vinylidene fluoride); poly(tetrafluoroethylene) (PTFE); polysiloxanes; and poly (methyl methacrylate).
Electrospun core-sheath fibers and other structures produced by the systems and methods of the invention may optionally include any suitable drug, compound, adjuvant, etc. and may be used for any indication that may occur to one skilled in the art. In preferred embodiments, the drug or other material chosen is insoluble in the polymers and solvents comprising the core polymer solution, or the concentration of drug or material used exceeds the solubility limit of the drug or material in the polymers or solvents. Without limiting the foregoing, general categories of drugs that are useful include, but are not limited to: opioids; ACE inhibitors; adenohypophoseal hormones; adrenergic neuron blocking agents; adrenocortical steroids; inhibitors of the biosynthesis of adrenocortical steroids; alpha-adrenergic agonists; alpha-adrenergic antagonists; selective alpha-two-adrenergic agonists; androgens; anti-addictive agents; antiandrogens; antiinfectives, such as antibiotics, antimicrobals, and antiviral agents; analgesics and analgesic combinations; anorexics; antihelminthics; antiarthritics; antiasthmatic agents; anticonvulsants; antidepressants; antidiabetic agents; antidiarrheals; antiemetic and prokinetic agents; antiepileptic agents; antiestrogens; antifungal agents; antihistamines; antiinflammatory agents; antimigraine preparations; antimuscarinic agents; antinauseants; antineoplastics; antiparasitic agents; antiparkinsonism drugs; antiplatelet agents; antiprogestins; antipruritics; antipsychotics; antipyretics; antispasmodics; anticholinergics; antithyroid agents; antitussives; azaspirodecanediones; sympathomimetics; xanthine derivatives; cardiovascular preparations, including potassium and calcium channel blockers, alpha blockers, beta blockers, and antiarrhythmics; antihypertensives; diuretics and antidiuretics; vasodilators, including general coronary, peripheral, and cerebral; central nervous system stimulants; vasoconstrictors; hormones, such as estradiol and other steroids, including corticosteroids; hypnotics; immunosuppressives; muscle relaxants; parasympatholytics; psychostimulants; sedatives; tranquilizers; nicotine and acid addition salts thereof; benzodiazepines; barbiturates; benzothiadiazides; beta-adrenergic agonists; beta-adrenergic antagonists; selective beta-one-adrenergic antagonists; selective beta-two-adrenergic antagonists; bile salts; agents affecting volume and composition of body fluids; butyrophenones; agents affecting calcification; catecholamines; cholinergic agonists; cholinesterase reactivators; dermatological agents; diphenylbutylpiperidines; ergot alkaloids; ganglionic blocking agents; hydantoins; agents for control of gastric acidity and treatment of peptic ulcers; hematopoietic agents; histamines; 5-hydroxytryptamine antagonists; drugs for the treatment of hyperlipiproteinemia; laxatives; methylxanthines; monoamine oxidase inhibitors; neuromuscular blocking agents; organic nitrates; pancreatic enzymes; phenothiazines; prostaglandins; retinoids; agents for spasticity and acute muscle spasms; succinimides; thioxanthines; thrombolytic agents; thyroid agents; inhibitors of tubular transport of organic compounds; drugs affecting uterine motility; anti-vasculogenesis and angiogenesis; vitamins; and the like; or a combination thereof.
The invention includes means for co-localizing sheath and core polymer solutions at multiple sites of Taylor cone formation during an electrospinning process so that core-sheath fibers are produced. In certain embodiments, devices of the invention comprise a hollow vessel having a lengthwise slit therethrough, through which a solution of the core polymer can be introduced. Flow of both core and sheath polymer solutions is initiated and an electric field is introduced. These steps are performed in any suitable order: for example, in some embodiments, flow of the core polymer solution is initiated, a field is introduced and Taylor cones and electrospinning jets comprising core polymer solution are formed; then sheath polymer flow is initiated such that the sheath polymer is incorporated into Taylor cones and electrospinning jets. In other embodiments, the sheath polymer flow is initiated first, then the field is introduced and, after formation of Taylor cones and electrospinning jets, the core polymer flow is initiated. In still other embodiments, both polymer solutions are provided simultaneously, then the field is introduced, etc.
Application of an electric field of sufficient strength to apparatuses of the invention leads to formation of Taylor cones and electrospinning jets in the polymer solution or solutions. In some embodiments, Taylor cones and electrospinning jets are formed in the core polymer solution 230, then the sheath polymer solution 260 is added alongside or above the core polymer solution 230 so that the sheath polymer solution 260 is drawn up into Taylor cones 240 and electrospinning jets 241. In preferred embodiments, Taylor cones and jets are formed in the sheath polymer solution 260 and the core polymer solution 230 is added, preferably beneath the sheath polymer solution 260, so that it is incorporated or pulled into electrospinning jets. As illustrated in
The vessels 210, 270 are made of a conducting material such as stainless steel, copper, bronze, brass, gold, silver, platinum, and other metals and alloys. Slits 220, 271 preferably have a width sufficient to permit formation of Taylor cones 240, generally between 0.01 and 20 millimeters, and preferably between 0.1 to 5 millimeters. The length of vessels 210, 270 is preferably between 5 centimeters and 50 meters, and more preferably between 10 centimeters and 2 meters.
Metals used to form portions of apparatuses of the invention may be polished, brushed, cast, etched (by acid or other chemical or mechanically) or unfinished. The metal finish may be chosen to affect an aspect of the performance of the apparatus; for example, the inventors have found that using polished brass improves the flow of polymer solution. Alternatively, non-metal materials or insulating materials may be used to form all or a part of the components used within the apparatuses of the present invention.
The materials used to form the core and sheath portions of the fibers formed in the present invention are placed into solution before being introduced into the apparatuses that are used for fiber formation. The core polymer solution preferably has a viscosity of between 1 and 100,000 centipoise, and is preferably pumped through the inner vessel 210 at rates of between 0.01 and 1000 milliliters per hour per centimeter, more preferably between 5 and 200 milliliters per hour per centimeter. A voltage, preferably between 1 and 250 kV, more preferably between 20-100 kV, is applied. The positive electrode of the power supply is preferably connected to one or both of the vessels 210, 270 such that a potential exists between one or both of the vessels and a grounded collector that is placed at a distance. In alternate embodiments the collector is oppositely charged relative to the polymer solution(s). In some embodiments, the collector 250 includes one or more grounded or oppositely charged points (for example, two grounded points separated by a space), and fibers collect around the one or more points and/or between them. Upon application of a sufficient voltage, Taylor cones 240 and electrospinning jets 241 will form at the exposed surface of core and/or sheath polymer solution(s) 230, 260 and the jets will attract towards the collector.
In preferred embodiments, core and/or sheath polymer solutions 230, 260 are provided to the interior and exterior, respectively, of the vessel 210 at the slit 220 in a steady, laminar fashion such that fluid velocity and pressure of the core and/or sheath polymers 230, 260 are constant across the width of the slit 230 over time. Such steady, laminar flow can be achieved by a variety of methods, which may be used alone or combined, and the inventors have found that driving polymer flow pneumatically, hydraulically, mechanically (piston-driven) or by gravity can result in a suitably consistent supply of the required fluids; this aim can also be met by employing flow directing structures such as diffusers in flow paths for the core and sheath polymers 230, 260.
With respect to pneumatic driving of fluids,
Any suitable gas may be used to drive the flow of core and/or sheath fluids 230, 260, including air, but in preferred embodiments a non-reactive or inert gas is used such as nitrogen, helium, argon, krypton, xenon, carbon dioxide, helium, nitrous oxide, oxygen, combinations thereof and the like. The gas used to drive flows is optionally insoluble in the solvents used in the core or sheath polymer solutions 230, 260 to prevent the formation of gas bubbles during electrospinning. Additional steps may be taken to prevent bubble formation during electrospinning, including de-gassing the core and sheath polymer solutions 230, 260 prior to use and separating the gas used to drive fluid flows from the polymer solutions 230, 260 through the use of an impermeable membrane or piston. In some embodiments, an inflatable balloon is used to displace polymer solutions 230, 260 from the reservoirs 231, 261. The reservoirs 231, 261 and the gas inputs 280 are preferably sufficiently airtight to prevent leakage at the gas pressures used.
As shown in
With respect to hydraulic driving of fluids, as shown in
In some embodiments, the piston includes one or more sealing features 286 such as gaskets or O-rings to prevent the driving fluid from mingling with the polymer solution. This aim may also be achieved in some embodiments by tailoring the surfaces of the piston 285 and/or the reservoir to repel the fluid 281 used to drive the piston 285—for example, in embodiments where water is used to drive the piston 285, the piston and the wall of the reservoir may include hydrophobic surfaces to prevent the migration of water past the piston.
With respect to piston-driven fluids, piston 285 may be made of any suitable material, including plastics, metals and combinations thereof. In some embodiments, the piston 285 is made of a material that is the same as or similar to a material included in the vessel 210; in other embodiments, the piston is non-conductive and/or includes a dielectric material. The piston preferably includes a material that is non-reactive with the polymer solutions 230, 260. The piston and/or the reservoir may include a coating or surface to render it non-reactive and/or to prevent a gas or liquid used to drive the piston from mingling with the polymer solution. The piston and/or the reservoir may also include a coating to minimize friction between the piston and the walls of the reservoir to prevent binding between the piston to the walls and variation in fluid velocities and pressures delivered to the slit 220.
Pistons may be driven pneumatically, hydraulically (as discussed above) or by mechanical actuators such as screw actuators or linear actuators. Multiple pistons may be used to drive core polymer solution 230 and sheath polymer solution 260. As shown in
Pressure diffusers can be used to even out flow across a vessel and/or a slit for electrospinning Pressure diffusers, as the term is used herein, refers to structures that obstruct at least a portion of a flow path to re-direct a relatively narrow stream of fluid over a larger area. A pressure diffuser may include holes, slits, or other apertures to permit fluid to flow through the diffuser. A diffuser may also include angled, curved, or beveled surfaces to force fluid contacting such surfaces to flow in desired directions around the diffuser. One or more diffusers can be arranged, in parallel or in series, across a flow path to more fully diffuse the flow of a solution. The diffuser can include surfaces parallel to, perpendicular to, or otherwise angled to a desired direction of flow. A selection of diffusers compatible with the invention are illustrated in
With respect to gravity-driven fluid flows, in such embodiments, a reservoir such as a core polymer solution reservoir 231 will be positioned above the hollow vessel 210 and the slit 220, such that the polymer solution 230/260 will flow downward by gravity from the reservoir toward the slit. The apparatus 200 includes a vent or valve through which air can enter the reservoir 231/261 to occupy space vacated by polymer solution 230/260 as it flows toward the slit 220.
In some embodiments, the polymers used in the present invention include additives such as drug particles, metallic or ceramic particles to yield fibers having a composite structure.
Other suitable vessel geometries may be used in accordance with the present invention, including round designs as shown in
In addition, although the disclosure focuses on systems and methods utilizing a single lengthwise slit, any suitable aperture geometry may be used, including without limitation multiple short slits, holes, curved slits, slits and holes together, etc. Similarly, the invention includes systems and methods utilizing complex three-dimensional arrangements, such as that shown in
Preferred embodiments of the invention utilize elongate areas including slits for electrospinning. Using elongate areas rather than, say, radially symmetrical or square areas advantageously permits multiple solutions or materials to be continuously and evenly supplied to sites of Taylor cone and electrospinning jet formation such that they are closely apposed, yet remain separate. In non-elongate areas such as squares, Taylor cones and electrospinning jets that form in the center of the area tend to deplete the supply of materials or polymer solutions in the center of the area, which materials cannot be replaced as efficiently and evenly while remaining in an unmixed fashion as is possible in narrower, more elongate areas. In addition, the use of elongate areas provides a straightforward path to scaling-up fiber production: as the long dimension of the elongate area increases, it is possible to form more Taylor cones and electrospinning jets within the area, yet by keeping a short dimension relatively constant, materials and polymer solution can be rapidly supplied from alongside or underneath the area to prevent depletion. Suitable dimensions for slits in apparatuses of the invention are disclosed in Examples 7 and 8, below.
The systems and methods described herein can be adapted to form structures other than core-sheath fibers. For example, core-sheath particles may be formed using core and/or sheath polymer solutions with low viscosity. Upon introduction on an electric field, Taylor cones and structures similar to electrospinning jets (which are referred to as “spray jets” herein) will form. Due to the low viscosity of the solutions, the spray jets will break-up midstream leading to particle formation. Optionally, vibration can be used to disrupt the flow of the core and/or sheath solutions to further encourage the formation of spray jets and/or particles.
The invention also includes combinations of the systems and methods described above. For example, structures incorporating multiple sheath polymers can be formed using a vessel/bath setup as described above in combination with a syringe pump to provide a second sheath polymer solution to sites of Taylor cone formation.
In some embodiments, one or more of the core polymer solution and the sheath polymer solution is delivered in a pulsatile manner to create fibers with gradients of core densities and/or sheath thicknesses.
The invention includes systems and methods in which limited or no structure is used to separate core and sheath polymer solutions 220, 260. As shown in
The devices and methods of the present invention may be further understood according to the following non-limiting examples:
Slit-surfaces of various geometries were fabricated and the formation of electrospinning jets from these surfaces was demonstrated.
Even flow of polymer solution to a slit was achieved by the use of a mechanical piston.
Even flow of polymer solution to the slit was achieved by incorporating pressure diffusers to divert momentum of fluid flow across the slit. Shown in
Another method for even flow can be achieved by redirecting polymer solution to flow in the opposite direction of initial direction. Shown in
Core-sheath fibers were manufactured using an apparatus according to the embodiment of
A sheath solution 260 of 2.8 wt % 85/15 PLGA in 6:1 (by vol) chloroform/methanol and a core solution 230 of 2.8 wt % 85/15 PLGA in 6:1 (by vol) chloroform/methanol containing 30% wt % dexamethasone drug with respect to PLGA was used. The sheath flow rate was set at 100 ml/h while the core flow rate was set at 50 ml/h. A voltage of 50 kV was applied.
Core-sheath fibers were manufactured using an apparatus according to the embodiment of
Fibers with various core-sheath structures were fabricated using an apparatus according to the embodiment of
An apparatus incorporating a round slit rather than a linear one has been used. A showerhead fixture was modified, replacing a center piece with a plug to form a circumferential slit. When a 1 wt % PLGA solution was provided to the slit, multiple Taylor cones and electrospinning jets were observed, as shown in
The term “and/or” is used throughout this application to mean a non-exclusive disjunction. For the sake of clarity, the term A and/or B encompasses the alternatives of A alone, B alone, and A and B together. The aspects and embodiments of the invention disclosed above are not mutually exclusive, unless specified otherwise, and can be combined in any way that one skilled in the art might find useful or necessary.
The term “elongate” is used throughout this application to refer to structures having at least two dimensions, one dimension being longer, and preferably substantially longer, than the other(s). For the sake of clarity, the term “elongate” encompasses structures that are linear, cylindrical, cuboidal, curved, curvilinear, toroidal, annular, angled, rectangular, etc. and any structure that could be formed by bending or curving one of the elongate structures listed above.
While several embodiments of the present invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the functions and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the teachings of the present invention is/are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described and claimed. The present invention is directed to each individual feature, system, article, material, kit, and/or method described herein. In addition, any combination of two or more such features, systems, articles, materials, kits, and/or methods, if such features, systems, articles, materials, kits, and/or methods are not mutually inconsistent, is included within the scope of the present invention.
The breadth and scope of the invention is intended to cover all modifications and variations that come within the scope of the following claims and their equivalents:
This invention was made with Government support under 70NANB11H004 awarded by the National Institute of Standards and Technology (NIST). The Government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
4764377 | Goodson | Aug 1988 | A |
5364627 | Song | Nov 1994 | A |
5538735 | Ahn | Jul 1996 | A |
5567612 | Vacanti et al. | Oct 1996 | A |
5569528 | Van der Loo et al. | Oct 1996 | A |
5700476 | Rosenthal et al. | Dec 1997 | A |
5842477 | Naughton et al. | Dec 1998 | A |
5922340 | Berde et al. | Jul 1999 | A |
5944341 | Kimura et al. | Aug 1999 | A |
5980927 | Nelson et al. | Nov 1999 | A |
6086911 | Godbey | Jul 2000 | A |
6214370 | Nelson et al. | Apr 2001 | B1 |
6382526 | Reneker et al. | May 2002 | B1 |
6495124 | Samour | Dec 2002 | B1 |
6520425 | Reneker | Feb 2003 | B1 |
6524608 | Ottoboni et al. | Feb 2003 | B2 |
6596296 | Nelson et al. | Jul 2003 | B1 |
6655366 | Sakai | Dec 2003 | B2 |
6676953 | Hexamer | Jan 2004 | B2 |
6676960 | Saito et al. | Jan 2004 | B2 |
6685956 | Chu et al. | Feb 2004 | B2 |
6685957 | Bezemer et al. | Feb 2004 | B1 |
6689374 | Chu et al. | Feb 2004 | B2 |
6695992 | Reneker | Feb 2004 | B2 |
6712610 | Abdennour et al. | Mar 2004 | B2 |
6716449 | Oshlack et al. | Apr 2004 | B2 |
6737447 | Smith et al. | May 2004 | B1 |
6753454 | Smith et al. | Jun 2004 | B1 |
6821479 | Smith et al. | Nov 2004 | B1 |
6855366 | Smith et al. | Feb 2005 | B2 |
6858222 | Nelson et al. | Feb 2005 | B2 |
6861142 | Wilkie et al. | Mar 2005 | B1 |
6861570 | Flick | Mar 2005 | B1 |
6913760 | Carr et al. | Jul 2005 | B2 |
7029495 | Stinson | Apr 2006 | B2 |
7033603 | Nelson et al. | Apr 2006 | B2 |
7033605 | Wong | Apr 2006 | B2 |
7048913 | Hexamer | May 2006 | B2 |
7048946 | Wong et al. | May 2006 | B1 |
7074392 | Friedman et al. | Jul 2006 | B1 |
7135194 | Birnbaum | Nov 2006 | B2 |
7172765 | Chu et al. | Feb 2007 | B2 |
7198794 | Riley | Apr 2007 | B1 |
7214506 | Tatsumi et al. | May 2007 | B2 |
7235295 | Laurencin et al. | Jun 2007 | B2 |
7285266 | Vournakis et al. | Oct 2007 | B2 |
7309498 | Belenkaya et al. | Dec 2007 | B2 |
7323190 | Chu et al. | Jan 2008 | B2 |
7462362 | Kepka et al. | Dec 2008 | B2 |
7678366 | Friedman et al. | Mar 2010 | B2 |
7737060 | Strickler et al. | Jun 2010 | B2 |
7765647 | Smith et al. | Aug 2010 | B2 |
7799965 | Patel et al. | Sep 2010 | B2 |
7803395 | Datta et al. | Sep 2010 | B2 |
7824699 | Ralph et al. | Nov 2010 | B2 |
7959616 | Choi et al. | Jun 2011 | B2 |
7959848 | Reneker et al. | Jun 2011 | B2 |
7959904 | Repka | Jun 2011 | B2 |
7997054 | Bertsch et al. | Aug 2011 | B2 |
8257614 | Gu et al. | Sep 2012 | B2 |
20010021873 | Stinson | Sep 2001 | A1 |
20020176893 | Wironen et al. | Nov 2002 | A1 |
20030017208 | Ignatious et al. | Jan 2003 | A1 |
20030068353 | Chen et al. | Apr 2003 | A1 |
20030118649 | Gao et al. | Jun 2003 | A1 |
20030195611 | Greenhalgh et al. | Oct 2003 | A1 |
20040030377 | Dubson et al. | Feb 2004 | A1 |
20040076661 | Chu et al. | Apr 2004 | A1 |
20040267362 | Hwang et al. | Dec 2004 | A1 |
20050033163 | Duchon et al. | Feb 2005 | A1 |
20050042293 | Jackson et al. | Feb 2005 | A1 |
20050106211 | Nelson et al. | May 2005 | A1 |
20050276841 | Davis et al. | Dec 2005 | A1 |
20060024350 | Varner et al. | Feb 2006 | A1 |
20060153815 | Seyda et al. | Jul 2006 | A1 |
20060293743 | Andersen et al. | Dec 2006 | A1 |
20070087027 | Greenhalgh et al. | Apr 2007 | A1 |
20070155273 | Chu et al. | Jul 2007 | A1 |
20070232169 | Strickler et al. | Oct 2007 | A1 |
20070293297 | Schugar | Dec 2007 | A1 |
20080053891 | Koops et al. | Mar 2008 | A1 |
20080281350 | Sepetka et al. | Nov 2008 | A1 |
20090155326 | Mack et al. | Jun 2009 | A1 |
20090196905 | Spada et al. | Aug 2009 | A1 |
20100184530 | Johnson | Jul 2010 | A1 |
20100249913 | Datta et al. | Sep 2010 | A1 |
20100291182 | Palasis et al. | Nov 2010 | A1 |
20100318108 | Datta et al. | Dec 2010 | A1 |
Number | Date | Country |
---|---|---|
WO-9418956 | Sep 1994 | WO |
WO-9853768 | Dec 1998 | WO |
WO-0132229 | May 2001 | WO |
WO-03020161 | Mar 2003 | WO |
WO-2007052042 | May 2007 | WO |
WO-2008013713 | Jan 2008 | WO |
WO-2008085199 | Jul 2008 | WO |
Entry |
---|
Bini, T.B. et al., “Electrospun poly(L-lactide-co-glycolide) biodegradable polymer nanofiber tubes for peripheral nerve regeneration”, Nanotechnology, 15, 2004, 1459-1464. |
Biomedical Structures, Glossary: Common Biomedical Textile Terms (accessed Oct. 12, 2011), 1-11 pgs. |
Cui, W. et al., “Electrospun fibers of acid-labile biodegradable polymers with acetal groups as potential drug carriers”, International Journal of Pharmaceutics, vol. 361 (1-2), pp. 47-55, (2008). |
Gyeong-Man, Kim et al., “Electrospun PVA/HAp nanocomposite nanofibers: biomimetics of mineralized hard tissues at lower level of complexity”, Bioinspiration & Biomimetics, vol. 3(4), pp. 1-12, (2008). |
Huang, Zheng-Ming et al., “A review on polymer nanofibers and electrospinning and their applications in nanocomposites”, Composites Science and Technology, 63:2223-2253, (2003). |
Jose, Moncy V. et al., “Fabrication and characterization of aligned nanofibrous FLGA/Collagen blends as bone tissue scaffolds”, Polymer, 50:3778-3785, (2009). |
Kanani et al., “Review on Electrospul Nanofibers Scaffold and Biomedical Applications”, Trends Biomater. Artif. Organs, vol. 24(2), 93-115, (2010). |
Kim, Chan et al., “Characteristics of supercapaitor electrodes of PBI-based carbon nanofiber web prepared by electrospinning”, Electrochimica Acta 50:877-881, (2004). |
Kostakova, Eva et al., “Composite nanofibers produced by modified needleless electrospinning”, Materials Letters, 63:2419-2422, (2009). |
Li, Wan-Ju, et al., “Biological response of chondrocytes cultured in three-dimensional nanofibrous poly(?-caprolactone) scaffolds” Journal of Biomed Mater Research, 67:1105-1114, (2003). |
Liao, Yiliang et al., “Preparation, characterization, and encapsulation/release studies of a composite nanofiber mat electrospun from an emulsion containing poly(lactic-co-glycolic acid)”, Polymer, 49:5294-5299, (2008). |
Liang, Dehai et al., “Functional electrospun nanofibrous scaffolds for biomedical applications” Advanced Drug Delivery Reviews 59:1392-1412, (2007). |
Liu, Shih-Jung et al. “Electrospun PLGA/collagen nanofibrous membrane as early-stage would dressing” Journal of Membrane Science, 355:53-59, (2010). |
Lowery, Joseph L. et al., “Effect of fiber diameter, pore size and seeding method on growth of human dermal fibroblasts in electrospun poly(ε-caprolactone) fibrous mats” Biomaterials, 31:491-504, (2010). |
Lukas, David, et al., “Self-organization of jets in electrospinning from free liquid surface: A generalized approach”, Journa lof Applied Physics, 103, 084309, (2008). |
McCann, Jesse T. et al., “Electrospinning of nanofibers with core-sheath, hollow, or porous structures”, Journal of Materials Chemistry, 15:735-738, (2005). |
Park, Jeong-Ho et al., “Coaxial electrospinning of self-healing coatings” Advanced Materials 22:496-499, (2010). |
Petrik, Stanislav et al., “Production nozzle-less electrospinning nanofiber technology” V Horkach 76/18, CZ-46007. |
Pham, Quynh P. et al., “Electrospun poly(ε-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration”, Biomacromolecules, 7:2796-2805, (2006). |
Ren, Guanglei, et al., “Electrospun poly(vinyl alcohol)/glucose oxidase biocomposite membranes for biosensor applications” Reactive & Functional Polymers, 66:1559-1564, (2006). |
Reneker, Darrell H. et al., “Nanometre diameter fibres of polymer, produced by electrospinning”, Nanotechnology, 7:216-223, (1996). |
Rhee et al, “Treatment of type II endoleaks with a novel polyurethane thrombogenic foam; Induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model” Journal of Vascular Studies, 42:2, 321-328, (2005). |
Rutledge, Gregory C., et al., “Formation of fibers by electrospinning”, Advanced Drug Delivery Reviews, 59:1384-1391, (2007). |
Sawicka, Katarzyna M. et al., “Electrospun composite nanofibers for functional applications”, Journal of Nanoparticle Research, 8:769-781, (2006). |
Sell, S.A., et al., “Electrospun polydioxanone-elastin blends: potential for bioresorbable vascular grafts” Biomedical Materials, 72-80, (2006). |
Sy, Jay C. et al., “Emulsion as a Means of Controlling Electrospinning of Polymers”, Advanced Materials, 21, 2009, 1814-1819. |
Tan, Songting, et al., “Mini-review some fascinating phenomena in electrospinning processes and applications of electrospun nanofibers” Polymer International 56:1330-1339, (2007). |
Theron, S.A. et al., “Multiple jets in electrospinning: experiment and modeling” Polymer, 46:2889-2899, (2005). |
Varabhas, J.S., et al., “Electrospun nanofibers from a porous hollow tube” Polymer, 49:4226-4229, (2008). |
Vonch, J. et al., “Electrospinning: A study in the formation of nanofibers”, Journal of Undergraduate Research 1, 1, (2007). |
Wang, Miao, et al., “Electrospinning of silica nanochannels for single moleculre detection”, Applied Physics Letters, 88, 033106, (2006). |
Wang, Xin, et al., “Needless electrospinning of nanofibers wtih a conical wire coil” Polymer Engineering and Science, 1583-1586 (2009). |
Wei, Kai et al., “Emulsion Electrospinning of a Collegen-like Protein/PLGA Fibrous Scaffold: Empirical Modeling and Preliminary Release Assessment of Encapsulated Protein”, Macromolecular Bioscience, 11:1526-1536, (2011). |
Wu, Dezhi et al., “High throughput tip-less electrospinning via a circular cylindrical electrode”, Journal of Nanoscience and Nanotechnology, 10:1-6, (2010). |
Wutticharoenmongkol, Patcharaporn et al. “Preparation and characterization of novel bone scaffolds based on electrospun polycaprolactone fibers”, Macromolecular Bioscience, vol. 6(1), pp. 70-77, (2006). |
Xu, X. et al. “BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glima C6 cells”, Journal of Controlled Release, vol. 114(3), pp. 307-316, (2006). |
International Search Report mailed Jan. 18, 2011 for International Application No. PCT/US2010/057010 (3pgs). |
International Search Report mailed Jan. 9, 2011 for International Application No. PCT/US2011/44448 1pg). |
International Search Report mailed Dec. 7, 2012 for International Application No. PCT/US12/0555361. |
Number | Date | Country | |
---|---|---|---|
20130241115 A1 | Sep 2013 | US |
Number | Date | Country | |
---|---|---|---|
61437886 | Jan 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13362467 | Jan 2012 | US |
Child | 13758173 | US |